Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 3, 1999

View Archived Issues

Peptide Therapeutics, PMC Enter $60M Vaccines Deal

New Osteoporosis Research Finds Critical Bone Gene

Objectors Say Public Voice Weighted To Favor GMOs

Genetic Mutations Multiply To 'Incredibly' High Level

Epidauros, Parexel Enter Pharmacogenomics Deal

Biovector Launches IPO To Fund Growing Research

Pharming Reports Producing Transgenic Female Calves

NTB Raises C$3M To Fuel Nervous-System Research

U.K. Boosting Biotech With Four-Year Program

Germany's Chemical Industry Explores Uses Of DNA Chips

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...